Stay informed and make well-informed decisions with our Ratings Table. Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback